Ignite Creation Date:
2024-05-06 @ 12:32 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03789617
Status:
RECRUITING
Last Update Posted:
2022-07-11
First Post:
2018-12-27
Brief Title:
A Multi-center Single-arm Open Phase IIIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell EBV Specific Autologous CD8 T Cell in Patients With Treatment Failed Epstein Barr Virus EBV-Positive Malignancies
Sponsor:
Eutilex
Organization:
Eutilex
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-27
First Submit QC Date:
December 27 2018
Study First Post Date:
2018-12-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-07
Last Update Post Date:
2022-07-11
Last Update Post Date Type:
ACTUAL